{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:57:25Z","timestamp":1758776245345,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ygyno.2022.07.029","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T03:32:58Z","timestamp":1659583978000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["What happens after menopause? (WHAM): A prospective controlled study of symptom profiles up to 12 months after pre-menopausal risk-reducing salpingo-oophorectomy"],"prefix":"10.1016","volume":"167","author":[{"given":"Katrina M.","family":"Moss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita D.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efrosinia O.","family":"Krejany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ygyno.2022.07.029_bb0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrendo.2017.180","article-title":"Symptoms of menopause - global prevalence, physiology and implications","volume":"14","author":"Monteleone","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ygyno.2022.07.029_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.06.039","article-title":"Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies","author":"Zhu","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.07.029_bb0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2018.12.014","article-title":"Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations a systematic review of risks and benefits","volume":"153","author":"Gordhandas","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2022.07.029_bb0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3109\/13697137.2015.1083003","article-title":"MsFLASH participants\u2019 priorities for alleviating menopausal symptoms","volume":"18","author":"Carpenter","year":"2015","journal-title":"Climacteric."},{"issue":"5","key":"10.1016\/j.ygyno.2022.07.029_bb0035","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/gme.0b013e3181dd1f95","article-title":"Symptom clusters during the late menopausal transition stage: observations from the Seattle midlife women\u2019s health study","volume":"17","author":"Cray","year":"2010","journal-title":"Menopause."},{"issue":"2","key":"10.1016\/j.ygyno.2022.07.029_bb0040","first-page":"1","article-title":"It is not just menopause: symptom clustering in the study of women\u2019s health across the nation","volume":"3","author":"Harlow","year":"2017","journal-title":"Women\u2019s Midlife Health."},{"issue":"6","key":"10.1016\/j.ygyno.2022.07.029_bb0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/GME.0000000000000122","article-title":"Endocrine biomarkers and symptom clusters during the menopausal transition and early postmenopause: observations from the Seattle midlife Women\u2019s health study","volume":"21","author":"Woods","year":"2014","journal-title":"Menopause."},{"issue":"2","key":"10.1016\/j.ygyno.2022.07.029_bb0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/GME.0000000000000516","article-title":"Symptom clusters among MsFLASH clinical trial participants","volume":"23","author":"Woods","year":"2016","journal-title":"Menopause."},{"issue":"5","key":"10.1016\/j.ygyno.2022.07.029_bb0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/gme.0b013e3182358d7c","article-title":"Using longitudinal profiles to characterize women\u2019s symptoms through midlife: results from a large prospective study","volume":"19","author":"Mishra","year":"2012","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.ygyno.2022.07.029_bb0060","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ygyno.2021.05.036","article-title":"What happens after menopause? (WHAM): a prospective controlled study of sleep quality up to 12 months after premenopausal risk-reducing salpingo-oophorectomy","volume":"162","author":"Hickey","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.07.029_bb0065","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/13697137.2012.746657","article-title":"Identifying symptom clusters during the menopausal transition: observations from the Seattle midlife Women\u2019s Health Study","volume":"16","author":"Cray","year":"2013","journal-title":"Climacteric."},{"issue":"1","key":"10.1016\/j.ygyno.2022.07.029_bb0070","doi-asserted-by":"crossref","first-page":"83.e1","DOI":"10.1016\/j.ajog.2018.10.002","article-title":"Hysterectomy status and all-cause mortality in a 21-year Australian population-based cohort study","volume":"220","author":"Wilson","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2022.07.029_bb0075","doi-asserted-by":"crossref","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020","volume":"18","author":"Daly","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"3","key":"10.1016\/j.ygyno.2022.07.029_bb0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10689-012-9527-5","article-title":"The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause","volume":"11","author":"Pezaro","year":"2012","journal-title":"Familial Cancer"},{"key":"10.1016\/j.ygyno.2022.07.029_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2016.05.011","article-title":"Hot flushes and night sweats symptom profiles over a 17-year period in mid-aged women: the role of hysterectomy with ovarian conservation","volume":"91","author":"Wilson","year":"2016","journal-title":"Maturitas."},{"issue":"1","key":"10.1016\/j.ygyno.2022.07.029_bb0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/GME.0000000000001422","article-title":"Exploring factors that impact uptake of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in high-risk women","volume":"27","author":"Hickey","year":"2020","journal-title":"Menopause."},{"issue":"1","key":"10.1016\/j.ygyno.2022.07.029_bb0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/GME.0000000000001422","article-title":"Exploring factors that impact uptake of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in high-risk women","volume":"27","author":"Hickey","year":"2020","journal-title":"Menopause."},{"issue":"1","key":"10.1016\/j.ygyno.2022.07.029_bb0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2018.10.040","article-title":"Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation","volume":"152","author":"Hall","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2022.07.029_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018758","article-title":"What happens after menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women","volume":"7","author":"Hickey","year":"2017","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.ygyno.2022.07.029_bb0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ygyno.2021.02.001","article-title":"What happens after menopause? (WHAM): a prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy","volume":"161","author":"Hickey","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.07.029_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ygyno.2021.07.029","article-title":"What happens after menopause? (WHAM): a prospective controlled study of vasomotor symptoms and menopause-related quality of life 12 months after premenopausal risk-reducing salpingo-oophorectomy","volume":"163","author":"Hickey","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.07.029_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.maturitas.2004.06.015","article-title":"Further psychometric property development of the menopause-specific quality of life questionnaire and development of a modified version, MENQOL-Intervention questionnaire","volume":"50","author":"Lewis","year":"2005","journal-title":"Maturitas."},{"issue":"2","key":"10.1016\/j.ygyno.2022.07.029_bb0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ygyno.2022.07.029_bb0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.smrv.2015.01.009","article-title":"The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis","volume":"25","author":"Mollayeva","year":"2016","journal-title":"Sleep Med. Rev."},{"issue":"3","key":"10.1016\/j.ygyno.2022.07.029_bb0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl. Psychol. Meas."},{"key":"10.1016\/j.ygyno.2022.07.029_bb0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jad.2019.02.029","article-title":"Assessment of perimenopausal depression: a review","volume":"249","author":"Willi","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.ygyno.2022.07.029_bb0145","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2022.07.029_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/002204261004000106","article-title":"Latent transition analysis: benefits of a latent variable approach to modeling transitions in substance use","volume":"40","author":"Lanza","year":"2010","journal-title":"J. Drug Issues"},{"issue":"MAY","key":"10.1016\/j.ygyno.2022.07.029_bb0155","article-title":"Longitudinal model building using latent transition analysis: an example using school bullying data","volume":"9","author":"Ryoo","year":"2018","journal-title":"Front. Psychol."},{"key":"10.1016\/j.ygyno.2022.07.029_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.maturitas.2018.01.012","article-title":"Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy","volume":"111","author":"Stuursma","year":"2018","journal-title":"Maturitas."},{"issue":"3","key":"10.1016\/j.ygyno.2022.07.029_bb0165","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/13697137.2017.1285879","article-title":"Impact of risk-reducing salpingo-oophorectomy in premenopausal women","volume":"20","author":"Vermeulen","year":"2017","journal-title":"Climacteric."},{"issue":"8","key":"10.1016\/j.ygyno.2022.07.029_bb0170","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/jamaoncol.2021.1590","article-title":"Association of salpingectomy with delayed oophorectomy versus salpingo-oophorectomy with quality of life in BRCA1\/2 pathogenic variant carriers: a nonrandomized controlled trial","volume":"7","author":"Steenbeek","year":"2021","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.07.029_bb0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1754045313489645","article-title":"The 2013 British Menopause Society & Women\u2019s health concern recommendations on hormone replacement therapy","volume":"19","author":"Panay","year":"2013","journal-title":"Menopause Int."},{"key":"10.1016\/j.ygyno.2022.07.029_bb0180","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.maturitas.2018.11.005","article-title":"Determinants of hormone therapy uptake and decision-making after bilateral oophorectomy (BO): a narrative review","volume":"120","author":"Siyam","year":"2019","journal-title":"Maturitas."},{"issue":"3","key":"10.1016\/j.ygyno.2022.07.029_bb0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1021119405814","article-title":"Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer","volume":"1","author":"Elit","year":"2001","journal-title":"Familial Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2022.07.029_bb0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2015.11.016","article-title":"Sexual activity and functioning after risk-reducing salpingo-oophorectomy: impact of hormone replacement therapy","volume":"140","author":"Johansen","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.07.029_bb0195","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/GME.0000000000001176","article-title":"Risk factors for sexual dysfunction in BRCA mutation carriers after risk-reducing salpingo-oophorectomy","volume":"26","author":"Chan","year":"2019","journal-title":"Menopause."},{"issue":"7","key":"10.1016\/j.ygyno.2022.07.029_bb0200","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/GME.0000000000001766","article-title":"A prospective controlled study of sexual function and sexually related personal distress up to 12months after premenopausal risk-reducing bilateral salpingo-oophorectomy","volume":"28","author":"Islam","year":"2021","journal-title":"Menopause."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822005133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822005133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:03:02Z","timestamp":1758772982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822005133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0090825822005133"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.07.029","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What happens after menopause? (WHAM): A prospective controlled study of symptom profiles up to 12 months after pre-menopausal risk-reducing salpingo-oophorectomy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}